ImmuPharma PLC (AIM:IMM), a specialist in drug discovery and development, announced that chief executive Tim McCarthy and chief operating officer Dr Tim Franklin will attend BIO-Equity from May 12-14, in San Sebastian, Spain. This key biotech event connects companies with investors and the global biopharma community, offering ImmuPharma crucial opportunities for discussions on global partnering deals across its portfolio.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com